Reckitt Benckiser Group plc (RB or 'the group') is engaged in the production and distribution of household cleaning, and health and personal care products. The group operates in Europe, North America, Australia, New Zealand and other developing markets and employs over 37 thousand people. Reckitt Benckiser has global reach with operations in 60 countries and sales in some 180 countries. In 2015, the company generated a global net revenue of approximately 8.87 billion pounds. RB's revenues are broken down into three main categories - health, home and hygiene - with other brands belonging to two further categories: food and portfolio brands. In the 2015 fiscal year, Reckitt Benckiser's hygiene products category generated about 3.59 billion pounds.
Near the end of July, 2014 the company had announced that it would be spinning off its pharmaceutical unit after concluding that the business that once accounted for a fifth of earnings doesn't fit into the company's focus on consumer health anymore. Reckitt Benckiser Pharmaceuticals Inc. manufactures, markets and/or distributes more than 47 drugs in the United States. The division gets almost all of its revenue from Suboxone, a drug to treat addiction to oploids including heroin.
Reckitt Benckiser's business strategy is aimed at responding to key global shifts and focusing on where they can make the biggest difference: the need for better health and hygiene behavior and the growing scarcity of water. Focus on reducing environmental impacts across the value chain and maximizing positive impacts on health and hygiene behavior through education and innovation is their top priority.